KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Debt to Equity (2019 - 2025)

Historic Debt to Equity for Vir Biotechnology (VIR) over the last 5 years, with Q1 2025 value amounting to $0.02.

  • Vir Biotechnology's Debt to Equity changed N/A to $0.02 in Q1 2025 from the same period last year, while for Mar 2025 it was $0.02, marking a year-over-year change of. This contributed to the annual value of $0.01 for FY2024, which is N/A changed from last year.
  • Vir Biotechnology's Debt to Equity amounted to $0.02 in Q1 2025.
  • Over the past 5 years, Vir Biotechnology's Debt to Equity peaked at $0.08 during Q3 2021, and registered a low of $0.01 during Q4 2024.
  • Over the past 3 years, Vir Biotechnology's median Debt to Equity value was $0.04 (recorded in 2021), while the average stood at $0.04.
  • Over the last 5 years, Vir Biotechnology's Debt to Equity had its largest YoY gain of 32623.92% in 2021, and its largest YoY loss of 3323.61% in 2021.
  • Over the past 3 years, Vir Biotechnology's Debt to Equity (Quarter) stood at $0.08 in 2021, then plummeted by 82.14% to $0.01 in 2024, then grew by 20.09% to $0.02 in 2025.
  • Its last three reported values are $0.02 in Q1 2025, $0.01 for Q4 2024, and $0.08 during Q3 2021.